Comparison of the Kinetics of Parenteral and Oral Gold

References

• Blocka K., Furst D. E., Landaw E. Single dose pharmacokinetics of auranofin in rheumatoid arthritis. J Rheumatol (Suppl 8) 1982; 9: 110
   Google Scholar
• Blodgett R. C., Heuer M. A., Pietrusko R. G. Auranofin - A unique oral chrysotherapeutic agent. Semin Arth Rheum, (in press).
   Web of Science ®Google Scholar
• Champion G. D., Bieri D., Browne C D., Day R. O., Graham G. G., Haavisto T. M., Sambrook P. N., Vallance J. B. Auranofin in rheumatoid arthritis. J Rheumatol (Suppl 8) 1982; 9: 137
   Google Scholar
• Cooperative Systematic Studies of Rheumatic Diseases. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Arth Rheum, (in press).
   Google Scholar
• Finkelstein A. E., Roisman F. R., Batista V. Oral chrysotherapy in rheumatoid arthritis: Minimum effective dose. J Rheumatol 1980; 7: 160
   PubMed Web of Science ®Google Scholar
• Gerber R. C., Paulus H. E., Bluestone R. Kinetics of aurothiomalate in serum and synovial fluid. Arth Rheum 1972; 75: 625
   Google Scholar
• Gerber R. C., Paulus H. E., Jennirch R. I. Gold kinetics following aurothiomalate therapy: Use of a whole-body radiation counter. J Lab Clin Med 1974; 83: 778
   PubMed Web of Science ®Google Scholar
• Gottlieb N. L., Smith P. M., Smith E. M. Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis 1974; 17: 171
   Google Scholar
• Gottlieb N. L., Smith P. M., Penneys N. S. Gold concentrations in hair, nail, and skin during chrysotherapy. Arth Rheum 1974; 17: 56
   PubMedGoogle Scholar
• Gottlieb N. L., Smith P. M., Smith E. M. Pharmacodynamics of 197Au and 195Au-labelled aurothiomalate in blood. Arth Rheum 1974; 17: 171
   PubMed Web of Science ®Google Scholar
• Gottlieb N. L., Smith P. M., Smith E. M. Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Arth Rheum 1976; 15: 16
   Google Scholar
• Gottlieb N. L., Gray R. G. Diagnosis and management of adverse reactions from gold compounds. J Anal Toxicol 1978; 2: 173
   Web of Science ®Google Scholar
• Gottlieb N. L., Major J. C. Ocular chrysiasis correlated with gold concentrations in the crystalline lens during chrysotherapy. Arth Rheum 1978; 21: 704
   PubMed Web of Science ®Google Scholar
• Gottlieb N. L. Gold compounds in rheumatic diseases. Textbook of Rheumatology 1981; 796
   Google Scholar
• Gottlieb N. L. Comparative pharmacokinetics of parenteral and oral gold compounds. J Rheumatol (Suppl 8) 1982; 9: 99
   Google Scholar
• Graham G. G., Havisto T. M., McNaught P. J., Browne C D., Champion G. D. The effect of smoking on the distribution of gold in blood. J Rheumatol 1982; 9: 527
   PubMed Web of Science ®Google Scholar
• Graham R., Billings R., Laurence M. Tissue gold levels after chrysotherapy. Ann Rheum Dis 1974; 33: 536
   PubMed Web of Science ®Google Scholar
• Hashimoto A., Maeda Y., Ito H., Okazaki M., Hara T. Corneal chrysiasis - a clinical study in rheumatoid arthritis patients receiving gold therapy. Arth Rheum 1972; 15: 309
   PubMed Web of Science ®Google Scholar
• James D. W., Ludvigsen N. W., Cleland L. G., Milazzo S. C. The influence of cigarette smoking on blood gold distribution during chrysotherapy. J Rheumatol 1982; 9: 532
   PubMed Web of Science ®Google Scholar
• Kean W. F., Anastassiades P. T. Long term chrysotherapy: Incidence of toxicity and efficacy during sequential time periods. Arth Rheum 1979; 22: 495
   PubMed Web of Science ®Google Scholar
• Lorber A., Jackson W. H., Simon T. M. Effect of chrysotherapy on cell mediated immune response. J Rheumatol (Suppl 8) 1982; 9: 37
   Google Scholar
• Mascarhenas B. R., Granda J. L., Freyberg R. H. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds - reinvestigated. Arth Rheum 1972; 15: 391
   PubMedGoogle Scholar
• Menard H. A., Beaudet F., Davis P. Gold therapy in rheumatoid arthritis: An interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. J Rheumatol (Suppl 8) 1982; 9: 179
   Google Scholar
• Parr R. M., Taylor D. M. The determination of gold in human liver by thermal neutron activation analysis. Phys Med Biol 1963; 8: 43
   PubMed Web of Science ®Google Scholar
• Penneys N. S., Kramer K., Gottlieb N. L. The quantitative distribution of gold in skin during chrysotherapy. J Invest Dermatol 1975; 65: 331
   PubMed Web of Science ®Google Scholar
• Penneys N. S., McCreary S., Gottlieb N. L. Intracellular distribution of radiogold: Localization to large granule membranes. Arth Rheum 1976; 19: 927
   PubMedGoogle Scholar
• Sharp J. T., Lidsky M. D., Duff J. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Arth Rheum 1977; 20: 1179
   PubMed Web of Science ®Google Scholar
• Sigler J. W., Bluhm G. B., Duncan H. Gold salts in the treatment of rheumatoid arthritis: A double-blind study. Ann Intern Med, 80: 21–74
   PubMed Web of Science ®Google Scholar
• Smith P. M., Smith E. M., Gottlieb N. L. Gold distribution in whole blood during chrysotherapy. J Lab Clin Med 1973; 82: 930
   PubMed Web of Science ®Google Scholar
• Tedersen S. M., Graabaek P. M. Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy. Ann Rheum Dis 1980; 39: 576
   PubMed Web of Science ®Google Scholar
• Van de Stadt R. J., Abbo-Tilstra B. Gold binding to blood cells and serum proteins during chrysotherapy. Ann Rheum Dis 1980; 39: 31
   PubMed Web of Science ®Google Scholar
• Walz D. T., Griswold D. E., Di Martino M. J. Distribution of gold in blood following administration of auranofin. J Rheumatol (Suppl 5) 1979; 6: 56
   Google Scholar
• Walz D. T., Di Martino J., Griswold D. E., Intoccia A. P., Flanagan T. L. Biological actions of auranofin. Am J Med, (in press).
   Web of Science ®Google Scholar
• Weisman M. H., Hardison W. G.M., Walz D. T. Studies of the intestinal metabolism of oral gold. J Rheumatol 1980; 7: 633
   PubMed Web of Science ®Google Scholar
• Zvaifler N. J. Gold and antimalarial therapy. Arthritis & Allied Conditions 1979; 9: 355
   Google Scholar